Condensed Statements Of Cash Flows - USD ($)	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net income (loss)	$ 3,346,133	$ 6,682,249
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, depletion and amortization	1,802,114	1,583,760
Impairment of producing properties	6,100,696	5,585
Provision for deferred income taxes	868,000	366,000
Gain from leasing fee mineral acreage	(34,371)	(78,922)
Proceeds from leasing fee mineral acreage	67,651	95,039
Net (gain) loss on sales of assets	(934,207)	2,163,359
Directors' deferred compensation expense	44,827	67,570
Total (gain) loss on derivative contracts	(3,347,002)	(2,836,168)
Cash receipts (payments) on settled derivative contracts	(810,839)
Restricted stock award expense	524,257	255,844
Other	30,157	37,138
Cash provided (used) by changes in assets and liabilities:
Natural gas, oil and NGL sales receivables	3,368,278	(1,591,085)
Other current assets	(309,051)	(325,780)
Accounts payable	(129,304)	(95,649)
Income taxes receivable		2,413,942
Other non-current assets	63,723	10,253
Income taxes payable	80,569	165,889
Accrued liabilities	(589,817)	(281,034)
Total adjustments	6,795,681	1,955,741
Net cash provided by operating activities	10,141,814	8,637,990
Investing Activities
Capital expenditures	(87,104)	(192,677)
Acquisition of minerals and overriding royalty interests	(14,499,014)	(11,643,827)
Net proceeds from sales of assets	1,137,730	4,586,492
Deposits received on held for sale assets	815,000
Net cash provided (used) by investing activities	(12,633,388)	(7,250,012)
Financing Activities
Borrowings under Credit Facility	10,000,000	4,000,000
Payments of loan principal	(5,000,000)	(1,500,000)
Net proceeds from equity issuance		(32,507)
Cash receipts from (payments on) off-market derivative contracts	(3,010,661)	(4,402,422)
Purchases of treasury stock	(52,460)
Payments of dividends	(726,462)	(332,210)
Net cash provided (used) by financing activities	1,210,417	(2,267,139)
Increase (decrease) in cash and cash equivalents	(1,281,157)	(879,161)
Cash and cash equivalents at beginning of period	3,396,809	2,438,511
Cash and cash equivalents at end of period	2,115,652	1,559,350
Supplemental Schedule of Noncash Investing and Financing Activities:
Dividends declared and unpaid	811,688	517,479
Gross additions to properties and equipment	14,710,613	15,183,829
Equity offering used for acquisitions		(3,510,001)
Net (increase) decrease in accounts payable for properties and equipment additions	(124,495)	162,676
Capital expenditures and acquisitions	$ 14,586,118	$ 11,836,504